Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
60442-30-0
96296-38-7
1584160-66-6
31529-27-8
132623-08-6
120716-95-2
2222165-17-3 | (1S)-2-METHYL-1-(2-PYRIDYL)PROPYLAMINE DIHYDROCHLORIDE | AA01DU4C | MFCD26954805
1332648-74-4 | (5-fluoro-2-((2,2,2-trifluoroethoxy)methyl)phenyl)boronic acid | AA01DU9X | MFCD16198486
1090911-74-2 | N-(6-Butyl-1,3-benzothiazol-2-yl)-3-[(2-cyanoethyl)sulfamoyl]benzamide | AA01DUVX | MFCD11807900
1199243-95-2 | 6-fluoro-3-chloro-2-pyridinecarboxylic acid | AA01DUZH | MFCD13185824
1261580-79-3 | 3-chloro-4-iodobenzene-1-sulfonyl chloride | AA01DV2P | MFCD18393340
1321539-25-6 | 2-[(4-chlorophenyl)methyl]benzaldehyde | AA01DV6G | MFCD31666111
1479616-78-8 | 3-(3-amino-4-methoxyphenyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione | AA01DV9Z | MFCD20216176
1509787-34-1 | (6-chloro-8-methylimidazo[1,2-a]pyridin-2-yl)methanamine | AA01DVDN | MFCD26698921
153195-41-6 | 5-(2,5-dioxopyrrolidin-1-yl)pentanoic acid | AA01DVH9 | MFCD08277390
1553622-44-8 | 2-(tert-butyl)-2-methylmorpholine | AA01DVKA | MFCD28636028